VP Venture Partners is a venture capital investment firm founded in 2020 and based in Zurich, Switzerland. The firm focuses on investing in healthcare companies, specifically within the life science, medical devices, diagnostics, digital health, and medtech sectors across Europe. By targeting innovative enterprises in these fields, VP Venture Partners aims to support the development of transformative healthcare solutions.
aTension.life is a company focused on advancing the diagnosis and treatment of hypertension through precision medicine. It employs cutting-edge mass spectrometry technology to identify the underlying causes of uncontrolled hypertension using a single blood sample. aTension.life aims to provide personalized diagnostic solutions that enhance patient care and support laboratories with accurate and reliable tools. The company's mission is to improve the quality of life for hypertensive patients by making advanced diagnostics widely accessible and enabling more effective, individualized therapies.
Hemotune
Series B in 2024
Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform aimed at treating various health conditions, particularly infections and blood-related diseases. Utilizing innovative magnetic blood purification technology, Hemotune's device employs magnetic beads to selectively and efficiently remove large biomolecules from the bloodstream. This approach focuses on addressing the immunological aspects of sepsis, enabling the targeted treatment of multiple disease pathways and improving patient outcomes in acute care settings.
Smart4Diagnostics
Convertible Note in 2023
Smart4Diagnostics GmbH is a Munich-based company founded in 2018 that specializes in the production of digital data fingerprints for human blood samples. The company has developed a device designed for precise blood sample measurement, aiming to enhance the accuracy and reliability of diagnostic processes. By focusing on innovative solutions in the medical technology sector, Smart4Diagnostics contributes to advancements in healthcare diagnostics.
Hemotune
Series B in 2022
Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform aimed at treating various health conditions, particularly infections and blood-related diseases. Utilizing innovative magnetic blood purification technology, Hemotune's device employs magnetic beads to selectively and efficiently remove large biomolecules from the bloodstream. This approach focuses on addressing the immunological aspects of sepsis, enabling the targeted treatment of multiple disease pathways and improving patient outcomes in acute care settings.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.